Cholangiocarcinoma (MSK, Clin Cancer Res 2018)

Summary

Cholangiocarcinoma (MSK, Clin Cancer Res 2018) is a study catalogued by cBioPortal DataHub under the cancer-type code chol. EvidenceHelix groups it with liver, bile duct and gallbladder studies.

Study description

Targeted sequencing (MSK-IMPACT) of 195 tumor samples (194 with matched normals) from 192 cholangiocarcinoma patients.

Text as published in the source's study metadata.

Citation & PubMed

Lowery et al. Clin Cancer Res 2018

Linked PubMed records: PMID 29848569

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

chol_msk_2018

Short name

CHOL (MSK 2018)

Source cancer-type code

chol

Reference genome

not given

Source access groups

not given

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.

Citations

Lowery et al. Clin Cancer Res 2018

• PubMed record 29848569 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Cholangiocarcinoma (ICGC, Cancer Discov 2017)

  Whole-exome sequencing and Targeted/Exome sequencing of 489 Cholangiocarcinoma samples from 10 countries.

  Liver, bile duct and gallbladderOther published and consortium studiesSource code cholPubMed 1

• Cholangiocarcinoma (National Cancer Centre of Singapore, Nat Genet 2013)

  Whole exome sequencing of 15 cholangiocarcinoma cases.

  Liver, bile duct and gallbladderOther published and consortium studiesSource code cholPubMed 1

• Cholangiocarcinoma (National University of Singapore, Nat Genet 2012)

  Exome Sequencing for Opisthorchis viverrini-related cholangiocarcinoma in 8 O.viverrini-related tumors and matched normal tissue.

  Liver, bile duct and gallbladderOther published and consortium studiesSource code cholPubMed 1

• Cholangiocarcinoma (TCGA, Firehose Legacy)

  TCGA Cholangiocarcinoma. Source data from GDAC Firehose (http://gdac.broadinstitute.org/runs/stddata__2016_01_28/data/CHOL/20160128/). Previously known as TCGA Provisional.

  Liver, bile duct and gallbladderTCGA Firehose LegacySource code chol

• Cholangiocarcinoma (TCGA, PanCancer Atlas)

  Cholangiocarcinoma TCGA PanCancer data. The original data is here (https://gdc.cancer.gov/about-data/publications/pancanatlas). The publications are here (https://www.cell.com/pb-assets/consortium/pancanceratlas/panca…

  Liver, bile duct and gallbladderTCGA PanCancer AtlasSource code cholPubMed 11

• Intrahepatic Cholangiocarcinoma (JHU, Nat Genet 2013)

  Exome sequencing of tumor/normal pairs from 32 intrahepatic cholangiocarcinoma cases and 8 gall bladder carcinoma cases.

  Liver, bile duct and gallbladderOther published and consortium studiesSource code cholPubMed 1

• Gallbladder Cancer (MSK, 2022)

  Targeted sequencing of 244 Gallbladder cases via MSK-IMPACT where investigators calculated the Overall survival time for 100 metastatic gallbladder patients.

  Liver, bile duct and gallbladderMSK studiesSource code gbcPubMed 1

• Gallbladder Cancer (MSK, Cancer 2018)

  Targeted Sequencing of 103 samples with matched normals from 101 Gallbladder cancer patients.

  Liver, bile duct and gallbladderMSK studiesSource code gbcPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.